Pentavalent Vaccine to Conquer India

The pentavalent vaccine is the vaccine equivalent of buy 1, get 5 free. It prevents against diphtheria, pertussis, tetanus, hepatitis B and haemophilus influenzae type B. A vaccine which kills 5 birds with one stone obviously has numerous advantages including: Less complaints from the kids! Lower shipping/transportation costs Lower packaging costs Fewer staff needed to administer the vaccination Less equipment …

India announces development of $1 rotavirus vaccine

The Government of India's Department of Biotechnology (DBT) and Bharat Biotech have announced the development of a rotavirus vaccine that will be sold at $1 per dose, once approved. Results from a Phase III clinical trial showed that the ROTAVAC® vaccine decreased the incidence of severe rotavirus diarrhoea by 56% during the first year of life, and the protection conferred …

What you need to know: Vaccines in Emerging Markets

According to Decision Resources, "Emerging markets, particularly the BRIC markets (Brazil, Russia, India, and China), promise to be new engines for pharma growth in the face of faltering growth rates and growing challenges in the traditional stronghold major markets."  Below, we look at several issues dealing with vaccine R&D, market potential, and partnerships in emerging markets.  As these markets continue …